Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

We are very pleased to inform you that Dr. Marc A. Gauthier has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Early Career Investigator Award, acknowledging his outstanding contributions to our Society...

Dear CBS Members, As you are aware, the COVID-19 pandemic has caused numerous disruptions around the world, and scheduled conferences are being either postponed or canceled...

We are very pleased to inform you that Dr. Paul Santerre has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Lifetime Achievement Award , acknowledging his outstanding contributions to our Society...

CBS is pleased to offer travel awards to assist students and post-doctoral fellows who are CBS members to present their accepted oral or poster abstracts at the 11th World Biomaterials Congress this May in Glasgow, Scotland...

Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...

Current synthetic vascular grafts VG lead to intimal hyperplasia and thrombosis which prevent their use in small diameter prostheses 6 mm ...

Osteoclastic activity influences bone remodelling process by degrading bone minerals and collagenADDIN RW...

Patients treated with radiotherapy for head neck cancer and patients with Sj gren s syndrome SS experience decreased saliva flow due to the loss of salivary gland SG acinar cells...

Bisphosphonates are calcium-binding drugs that inhibit the bone-resorbing function of osteoclasts1. Nitrogen-containing bisphosphonates target farnesyl diphosphate synthase, an enzyme of the mevalonate pathway...